Phagelux announces multiple agricultural commercial collaborations

Canadian Poultry magazine
June 19, 2018
By Canadian Poultry magazine
Phagelux, Inc. a global biotechnology company focused on the development and commercialization of novel phage and lysin antibacterial products and solutions, made multiple announcements by entities within its agricultural division.

Tyler Homer, director of U.S. Operations for OmniLytics, a wholly owned subsidary of Phagelux, Inc., announced that OmniLytics has entered into a product development collaboration with NutriQuest to co-develop phage-based feed additive products.

Homer stated, "We are delighted to be working with one of the most innovative and fastest growing feed additive companies to create some truly unique and valuable new products."

Steve Weiss, president for NutriQuest added, "This partnership couples the OmniLytics leadership position in creating phage-based solutions with our expertise in the feed additives business to create what we believe will be very important new solutions for poultry and livestock producers. Producers are losing access to valuable tools in poultry and livestock production that are resulting in increased costs and we believe the solutions we create together will fill those critical needs and provide a high level of value."

Phagelux, Inc. has significant agricultural research, development and manufacturing capabilities in China.

William Wang, COO of Phagelux in China noted that Phagelux has added eleven new distributors to the Phagelux AgriHealth distribution network since January 1, 2018.

Wang noted that, "Although the line of our animal health products is still limited, and although we are just starting our sales efforts, the market seems to be responding positively to our products. In many agricultural categories treatments based on traditional antibiotics are either failing, or the public is demanding growers use less, and our products provide safe and natural alternatives that are often even more effective than traditional chemical antibiotics."

Add comment


Security code
Refresh

Subscription Centre

 
New Subscription
 
Already a Subscriber
 
Customer Service
 
View Digital Magazine Renew

Most Popular

We are using cookies to give you the best experience on our website. By continuing to use the site, you agree to the use of cookies. To find out more, read our Privacy Policy.